Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients

Table 5 Correlates affecting MetS scores in male and female patients: a multiple linear regression model

	Coefficients	Std. error	t	p-value	95% CI
	B	Std. error	t	p-value	Lower	Upper
Male
TC—mmol/L	0.13	0.73	0.18	0.858	− 1.48	1.74
LDL-C—mmol/L	− 0.07	0.64	− 0.11	0.915	− 1.47	1.33
FT₄—pmol/L	− 0.11	0.13	− 0.87	0.401	− 0.39	0.17
CGI—SI	− 0.01	0.41	− 0.02	0.988	− 0.90	0.89
Female
Age—years	0.10	0.03	3.31	0.002*	0.04	0.15
Onset age—years	− 0.07	0.03	− 2.10	0.041*	− 0.14	0.00
LDL-C—mmol/L	0.37	0.16	2.32	0.024*	0.05	0.69
HGB—g/L	− 0.05	0.01	− 3.41	0.001*	− 0.07	-0.02
WBC—10⁹/L	0.12	0.06	1.91	0.062	− 0.01	0.24
CRE—mmol/L	0.03	0.01	3.76	< .001*	0.01	0.04
PANSS	0.03	0.01	3.64	0.001*	0.02	0.05

TC total cholesterol, LDL-C low-density lipoprotein cholesterol, FT₄ free tetraiodothyronine, CGI-SI Clinical Global Impression Scale—Severity of Illness, HGB hemoglobin, WBC white blood cell, CRE blood creatinine, PANSS Positive and Negative Syndrome Scale. *p < 0.05

ISSN: 1744-859X